Abstract
Background
Herpes simplex virus (HSV) is an uncommon but important cause of brainstem rhomboencephalitis, especially in immunocompetent individuals. Its presentation can mimic demyelinating disorders such myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and neuromyelitis optica spectrum disorder (NMOSD), posing a diagnostic challenge.
Case Presentation
We report a case of a 31-year-old previously healthy male who presented with holocranial headache followed by bilateral limb and facial numbness, right hemibody sensory loss, left temporal visual field deficit, and unsteadiness while walking. Neurological examination revealed dissociated sensory loss, gaze-evoked nystagmus, and impairment of cranial nerve functions, including visual field deficit and facial sensory loss, indicating involvement of the optic and trigeminal nerves, respectively. MRI showed hyperintensities in the pontine tegmentum and middle cerebellar peduncles with enhancement of bilateral trigeminal nerves. CSF analysis revealed lymphocytic pleocytosis. MOG and AQP4 antibodies were negative. VEP showed left optic pathway involvement. Initial treatment with intravenous methylprednisolone showed no improvement. A viral etiology was considered, and CSF PCR was positive for HSV. The patient improved significantly following a 21-day course of intravenous acyclovir.
Conclusion
This case underscores the importance of considering HSV rhomboencephalitis in the differential diagnosis of brainstem syndromes, particularly those mimicking demyelination. Early identification and antiviral therapy are crucial to prevent long-term neurological sequelae.
Keywords: Herpes simplex virus (HSV), Rhomboencephalitis, Brainstem syndrome, Demyelinating disorders, CSF PCR
Introduction
Rhomboencephalitis refers to inflammation of the rhombencephalon (brainstem and cerebellum) and can arise from various etiologies, including infections, autoimmune disorders, paraneoplastic syndromes, and demyelinating conditions. Distinguishing these causes is crucial, as early treatment significantly influences outcomes. Infectious rhomboencephalitis, characterized by inflammation of the brainstem and cerebellum, is most commonly associated with Listeria monocytogenes, enteroviruses (particularly Enterovirus 71), and herpesviruses, including Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV), and Epstein-Barr Virus (EBV). Less frequently, Cytomegalovirus (CMV), Human Herpesvirus 6 (HHV-6), and Mycobacterium tuberculosis have been implicated. HSV-associated brainstem encephalitis may mimic demyelinating conditions such as Neuromyelitis optica spectrum disorders (NMOSD), Acute Disseminated Encephalomyelitis (ADEM) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD), especially in monophasic forms without classical encephalopathy or seizures [1–3]. While HSV encephalitis is more frequently seen in immunocompetent individuals, the rhombencephalitis pattern in HSV, or disseminated involvement, may actually be more common in immunocompromised patients. To date, only one case report of HSV-1–associated rhomboencephalitis and two case reports of HSV-2–related brainstem rhomboencephalitis have been documented in the literature. In addition to Listeria, other infectious agents that can cause rhomboencephalitis include enteroviruses, VZV, EBV, HIV, and TB, though HSV remains a rare cause in comparison. This case presents a diagnostically challenging instance of brainstem HSV rhomboencephalitis, initially presenting with multifocal sensory deficits and transient visual symptoms.
Case presentation
A 31-year-old right-handed male bus driver, with no significant past medical history except chronic tobacco use, presented with a 3-day history of holocranial headache. On the following day, he developed numbness affecting both upper and lower limbs, as well as reduced sensation over the bilateral face and the right side of his body, including the chest and trunk. One day later, he experienced reduced vision in the left temporal visual field. Additionally, he had difficulty walking, characterized by swaying to the right, which was more pronounced in the dark or with his eyes closed. There were no associated symptoms of motor weakness, seizures, personality changes, or signs of raised intracranial pressure. He denied fasciculations, band-like sensations, nuchal rigidity, bladder or bowel dysfunction, or changes in voice or phonation.
Neurological examination findings
Upon examination, the patient’s higher mental functions were intact (MMSE score − 28). Sensory deficits suggested dorsal and lateral column involvement, particularly over the right face, upper and lower limbs, and trunk. Muscle tone, strength, and deep tendon reflexes were normal, with flexor plantar responses. No pathological reflexes (such as Hoffman and Wartenberg signs) were elicited. The cerebellar examination was unremarkable except for Romberg’s sign, which was positive, with instability toward the right. Cranial nerve examination revealed no relative afferent pupillary defect (RAPD), preserved light reflexes, and gaze-evoked nystagmus in both horizontal and vertical planes. Ocular pursuit and saccadic movements were intact, and the jaw jerk was absent.
Investigations and differential diagnosis
The routine laboratory investigations revealed normal CBC, DLC, and liver and kidney function, with no abnormalities in blood parameters (Table 1). Initial differential diagnosis included demyelinating disorders (such as MOGAD, ADEM and NMOSD), viral rhomboencephalitis, and vasculitis. Autoimmune screening (ANA, ANCA), and viral markers (HIV, HBsAG, HCV), were negative. The MRI scans revealed T2/FLAIR hyperintensities in the pons, primarily affecting the pontine tegmentum and bilateral trigeminal nerve tracts. Additionally, hyperintensity was noted along the left hemi-medulla (Fig. 1). MOGAD was considered as the initial working diagnosis because of the brainstem lesion and visual involvement, which were suggestive of a demyelinating process, but without classical MS features such as periventricular lesions or typical optic nerve involvement. Fundus examination was normal, and visual acuity was measured at 6/24 in both eyes. HUF (Humphrey Visual Field) perimetry did not show initial field defects. CSF analysis revealed lymphocytic pleocytosis with normal glucose and protein levels. MRI of the brain with orbit screening showed hyperintensities in the pontine tegmentum and middle cerebellar peduncles, along with enhancement of the bilateral trigeminal tracts and root entry zones. There was sparing of the optic nerves, and no involvement of the diencephalon, periventricular regions, or spinal cord. Anti-AQP4 and anti-MOG antibodies were negative. Neuro-Behçet’s disease was considered, but no corroborative features (e.g., oral/genital ulcers, pathergy, uveitis) were present. Visual Evoked Potential (VEP) showed increased P100 latency, suggesting conduction delay along the visual pathway. This abnormality, despite a normal MRI, indicates subclinical demyelination, as VEP can detect such changes before they are evident on imaging. A working diagnosis of a monophasic demyelinating illness, likely MOGAD, was made.
Table 1.
Laboratory investigations
| Parameter | Result | Normal Range |
|---|---|---|
| Complete Blood Count (CBC) | ||
| Hb (g/dL) | 15.1 | 13–17 |
| TLC (x10^3/uL) | 10.36 | 4.0–11.0 |
|
DLC (%) (N/L/M/E |
63.6/24.2/9.2/2.4/0.1 | Neutrophils: 40–60%, Lymphocytes: 20–40%, Monocytes: 2–8%, Eosinophils: 1–4%, Basophils: 0.5-1% |
| HCT (%) | 46.8 | 38.3–48.6 |
| PLT (x10^3/uL) | 295 | 150–450 |
| MCV (fL) | 90.1 | 80–100 |
| CSF studies | ||
| Cytology |
Color: Colorless Appearance: Clear Clot/Coagulum: Absent Improved Neubauer’s Chamber Count: RBC- 20 cells/cumm WBC- 13 cells/cumm Microscopic Examination: Post centrifugation smears examined are paucicellular showing occasional lymphomononuclear cells in a clear background. No atypical cells seen. |
|
| CSF Biochemistry |
Glucose: 69 mg/dL Chloride:129 mmol/L Protein: 35 mg/dL |
Glucose : 45–80 mg/dL Chloride: 118–130 mmol/L Protein: 15–60 mg/dL |
| CSF Viral PCR |
HSV 1 – Detected HSV 2 – Not Detected Adenovirus – Not Detected Enterovirus – Not Detected Epstein Barr Virus – Not Detected Varicella Zoster Virus – Not Detected Cytomegalovirus – Not Detected Human herpesvirus 6 - Not Detected Human herpesvirus 7 - Not Detected |
|
| NMO; Anti Aquaporin 4 IgG | Negative | |
| MOG antibodies | Negative | |
| Serum and CSF OCB | No band | |
Fig. 1.
Axial T2 MRI images [1, 2] and Sagittal, coronal, and axial (3 to 5) Flair MRI images of the brain show T2/Flair hyperintensity in the pons predominantly involving the pontine tegmentum and bilateral trigeminal nerve tracts. T2 flair hyperintensity is also seen along the left hemi-medulla
Treatment and outcome
Intravenous methylprednisolone (15 mg/kg) was administered for 5 days, but the patient showed no clinical improvement. In light of the lack of response to steroids, an infectious etiology was reconsidered, and multiplex CSF BioFire testing was performed. The CSF PCR test returned positive for herpes simplex virus 1 (HSV-1). Following this, intravenous acyclovir therapy was initiated, and the patient showed significant improvement over the next three weeks. By the end of the 21-day course of antiviral treatment, the patient experienced complete resolution of visual and sensory deficits. At follow-up, his visual acuity and gait were normal, and a repeat neurological examination revealed no residual deficits.
Discussion
Diagnostic challenge and autoimmune mimics
HSV encephalitis most commonly involves the temporal lobes, but rare variants with predominant brainstem involvement have been reported, particularly in immunocompetent young adults [4]. The absence of typical temporal lobe signs and encephalopathy can delay diagnosis. The presenting features in our patient—dissociated sensory loss, gaze-evoked nystagmus, and postural instability—are more characteristic of demyelinating disorders such as MOGAD, NMOSD or ADEM [5, 6]. These overlapping symptoms can lead to misdiagnosis, particularly when imaging findings, including involvement of the middle cerebellar peduncles and cranial nerve enhancement, further mimic demyelinating pathology.
Imaging findings and literature comparison
MRI findings in our patient showed T2/FLAIR hyperintensity involving the pons, specifically the pontine tegmentum, and bilateral trigeminal nerve tracts. These imaging features are highly suggestive of demyelination, but they also align with those observed in previous cases of HSV-related rhomboencephalitis, as demonstrated in a case reported by Tien and Dillon, where a 33-year-old male developed left facial numbness with MRI showing T2 hyperintensity in the pons and middle cerebellar peduncle, as well as gadolinium enhancement of the cisternal segment of the trigeminal nerve [7]. This case mirrors our findings, particularly in terms of MRI features and cranial nerve involvement, underscoring the potential for HSV to masquerade as demyelinating conditions through retrograde viral spread from the trigeminal ganglion.
In our case, the Visual Evoked Potential (VEP) showed increased P100 latency, suggesting conduction delay along the visual pathway. This abnormality, despite a normal MRI, indicates subclinical demyelination, as VEP can detect such changes before they are evident on imaging. MRI findings, including normal optic nerves, do not exclude demyelination, as VEP abnormalities can occur even in the absence of visible lesions on MRI. Additionally, the reduced amplitude of the VEP may indicate axonal loss, pointing to a more permanent and irreversible insult rather than a transient dysfunction.
Role of CSF PCR in confirming HSV
The definitive diagnosis in our case was confirmed by HSV PCR positivity in CSF, a diagnostic test with high sensitivity (94%) and specificity (96–97%) [8]. Although HSV typically affects the temporal lobes, variants with predominant brainstem involvement have been increasingly recognized, particularly in immunocompetent hosts. This entity may mimic autoimmune demyelination both clinically and radiologically, often leading to delayed initiation of appropriate antiviral therapy if not promptly considered [4, 9].
Treatment response and steroid use
Given the clinical suspicion for a demyelinating monophasic illness, the patient in our report was initially treated with IV methylprednisolone. Though corticosteroids are not standard treatment for HSV encephalitis, some studies suggest adjunctive steroids may be beneficial in controlling excessive inflammation, especially in brainstem syndromes mimicking autoimmune demyelination [10]. Upon confirmation of HSV PCR positivity, IV acyclovir was appropriately initiated, leading to significant clinical improvement. The rapid neurological recovery observed after a combined antiviral and anti-inflammatory approach emphasizes the importance of early therapeutic intervention.
Clinical implications and learning points
This case demonstrates the diagnostic complexity in young patients presenting with multifocal neurological deficits and brainstem MRI changes. It underscores the need for considering HSV-related rhomboencephalitis in the differential diagnosis, particularly in cases mimicking MOGAD or NMOSD. The use of MRI characteristics, CSF analysis, and targeted PCR assays is critical for timely diagnosis and intervention. MOGAD and NMOSD are important differentials in young adults with brainstem syndromes. However, in this case, the absence of longitudinally extensive spinal cord lesions, optic nerve sparing on imaging, and negative antibody titers made these less likely. Behçet’s disease, another mimic of rhomboencephalitis, was excluded based on clinical features, pathergy negativity, and lack of uveitis or oral/genital ulcers.
Prompt initiation of IV acyclovir and corticosteroids led to rapid neurological improvement. Although steroids are not standard in HSV encephalitis, their use in cases with extensive inflammation and radiological resemblance to demyelination may be beneficial [9]. This case underscores the importance of integrating clinical presentation, imaging, serological, and molecular diagnostics in distinguishing infectious from immune-mediated rhomboencephalitis. Timely antiviral therapy is crucial, as delays are associated with higher morbidity and risk of permanent neurological deficits.
Conclusions
This case highlights the diagnostic challenge of brainstem syndromes in young adults, where clinical and radiological features can closely resemble demyelinating conditions like MOGAD or NMOSD. Trigeminal nerve enhancement, sensory dissociation, and visual pathway involvement initially pointed to a monophasic demyelinating process. However, the patient’s lack of response to corticosteroids and subsequent HSV PCR positivity in CSF led to the diagnosis of viral rhomboencephalitis. This highlights the importance of considering viral etiologies in atypical demyelinating presentations. Early identification and timely antiviral therapy not only facilitate neurological recovery but also prevent unnecessary immunosuppressive treatments, ensuring better patient outcomes.
Acknowledgements
Not applicable.
Abbreviations
- ADEM
Acute disseminated encephalomyelitis
- ANA
Antinuclear antibody
- ANCA
Antineutrophil cytoplasmic antibody
- AQP4
Aquaporin–4
- CBC
Complete blood count
- CMV
Cytomegalovirus
- CSF
Cerebrospinal fluid
- DNA
Deoxyribonucleic acid
- EBV
Epstein–Barr virus
- FLAIR
Fluid–attenuated inversion recovery
- HHV
Human herpesvirus
- HSV
Herpes simplex virus
- HUF
Humphrey Visual Field
- MOGAD
Myelin oligodendrocyte glycoprotein antibody–associated disease
- MRI
Magnetic resonance imaging
- MS
Multiple sclerosis
- NMO
Neuromyelitis optica
- NMOSD
Neuromyelitis optica spectrum disorder
- OCB
Oligoclonal bands
- PCR
Polymerase chain reaction
- RAPD
Relative afferent pupillary defect
- TB
Tuberculosis
- VEP
Visual evoked potential
- VZV
Varicella–zoster virus
Authors’ contributions
NL, MAT, PB, UK, ZS, and SDT were involved in the conception and design of the study, acquisition of clinical data, literature review, and drafting of the manuscript. HY contributed to the acquisition, analysis, and interpretation of radiological findings, and assisted in manuscript drafting. DK and MKG, as senior faculty, provided critical revision of the manuscript for important intellectual content, ensured methodological accuracy, and supervised the overall project. All authors contributed to the interpretation of data and approved the final version of the manuscript.
Funding
No funding was provided or sought.
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
It was taken and written informed consent was obtained from the patient for the publication of clinical details and imaging findings included in this manuscript.
Consent for publication
Informed consent was obtained from the patient for the publication of clinical details and imaging findings included in this manuscript.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Saiz A, Arpa J, Sagasta A, et al. Brainstem rhomboencephalitis: a series of 97 patients. Med Clin (Barc). 1998;110(1):1–5.9527978 [Google Scholar]
- 4.Creutzfeldt CJ, Padmanabhan V, Stence NV, et al. Herpes simplex virus type 1 rhomboencephalitis in immunocompetent adults. J Neurol. 2015;262(5):1261–7. [Google Scholar]
- 5.Dubey D, Pittock SJ, Krecke KN, et al. Clinical, radiologic, and prognostic features of Myelin oligodendrocyte glycoprotein antibody–associated encephalomyelitis in adults. JAMA Neurol. 2017;74(3):287–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Takai Y, Misu T, Kaneko K, et al. Myelin oligodendrocyte glycoprotein antibody–associated disease: an overview. Front Neurol. 2020;11:153.32210907 [Google Scholar]
- 7.Tien RD, Dillon WP. Herpes trigeminal neuritis and rhombencephalitis on Gd-DTPA-enhanced MR imaging. AJNR Am J Neuroradiol. 1990 Mar-Apr;11(2):413–4. PMID: 2107732; PMCID: PMC8334677. [PMC free article] [PubMed]
- 8.DeBiasi RL, Kleinschmidt-DeMasters BK, Weinberg A, Tyler KL. Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol. 2002;25(Suppl 1):S5-11. [DOI] [PubMed] [Google Scholar]
- 9.Dhasmana R, Gupta M, Jain R, et al. Herpes simplex virus-2 brainstem encephalitis in an immunocompetent adult. Am J Med. 2014;127(7):e3-4. [Google Scholar]
- 10.Prasad K, Garner P. Steroids for treating herpes simplex virus encephalitis. Cochrane Database Syst Rev. 2008;4CD002897.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

